Haixia Qi1 · Tao Zhang2 · Lijie Hou3 · Qi LI4 · Ruiping Huang3 · Lihua Ma1,3
Received: 23 December 2024 / Accepted: 29 March 2025 / Published online: 19 April 2025 © The Author(s) 2025, corrected publication 2025
Abstract
Objective This study aimed to comprehensively review the latest advancements in diabetic foot risk prediction models over the past four years to address the severe challenges posed by diabetic foot ulcers, which are among the leading causes of disability and mortality among diabetic patients. Diabetic foot ulcers are characterized by their complex aetiology, pose a grave threat to life and impose enormous social and economic burdens, thus becoming a critical issue in public health that urgently requires attention. By accurately predicting the risk of diabetic foot and implementing early intervention strategies, this study aimed to reduce its incidence and mortality rates.
Methods This study employed a systematic review and comprehensive analysis framework, conducted extensive searches of electronic databases (including PubMed, EMBASE, the Cochrane Library, CNKI, etc.) and supplemented these searches with manual literature collection to ensure comprehensive information coverage. During the literature screening and evalua-tion phase, strict adherence to the predetermined inclusion and exclusion criteria was maintained to guarantee the high qual-ity of the included studies. Further detailed quality assessments, data extraction, and analysis of the selected literature were conducted, with a focus on exploring the construction strategies of risk prediction models, the selection of key variables, the evaluation indicators of model performance, and the validation methods.
Results By comparing and analysing the differences among studies in terms of methodology, model effectiveness, and prac-tical application potential, this study summarized the development trends of diabetic foot risk prediction models and antici-pated future research directions. These findings indicate that with the assistance of advanced diabetic foot risk prediction models, potential risk factors can be identified and addressed early on, thereby effectively reducing the incidence of diabetic foot and significantly improving patients’ quality of life.
Conclusion This study revealed that diabetic foot risk prediction models have significant effects on accurately identifying risk factors and guiding early interventions, serving as effective tools to reduce the incidence of diabetic foot. Through early identification and intervention, the prognosis and quality of life of patients can be significantly improved, providing impor-tant references and guidance for the field of public health.
Keywords Diabetic foot ulcer · High-risk diabetic foot · Diabetes · Prediction model
Gabriele Angelo Vassallo1 · Tommaso Dionisi2,3 · Vittorio De Vita4 · Giuseppe Augello1 ·Antonio Gasbarrini3,5 · Dario Pitocco6 · Giovanni Addolorato2,3
Received: 25 January 2025 / Accepted: 29 March 2025 / Published online: 19 April 2025 © The Author(s) 2025
Fecal microbiota transplantation (FMT) has emerged as a potential therapeutic strategy for modulating gut dysbiosis in diabetes mellitus. This review critically evaluates preclinical and clinical evidence on FMT in type 1 (T1D) and type 2 dia-betes (T2D). Studies suggest that FMT can restore microbial diversity, improve glycemic control, and modulate immune responses, with varying effects across diabetes subtypes. In T1D, preclinical models demonstrate that FMT influences regulatory T-cell expansion and β-cell preservation, though clinical translation remains limited. In T2D, FMT has shown transient improvements in insulin sensitivity, with sustained effects observed only in patients with specific microbiome signatures. However, heterogeneity in patient responses, donor variability, and methodological limitations complicate its clinical application. This review highlights the interplay between FMT, immune modulation, and microbial metabolism, advocating for phenotype-stratified trials and multi-omics integration to enhance therapeutic precision.
Keywords Fecal microbiota transplantation · Intestinal Microbiome · Diabetes · Insulin sensitivity · Metabolic syndrome · Beta-cell
Abbreviations
FMT Fecal microbiota transplantation TUDCA Tauroursodeoxycholic acid VEGF Vascular endothelial growth factor SCFAs Short-chain fatty acids MMTT Mixed meal tolerance test FVT Fecal virome transplantation OGTT Oral glucose tolerance test SRB Sulfate-reducing bacteria LSI Lifestyle intervention
原创: 十六点五 中山二院糖尿病足中心
对于外周血管病变的介入治疗,较IWGDF指南较有关OFFLOADING的细节描述,有关介入治疗的部分实在是比较粗慥,目前糖尿病外周血管病变介入治疗的热点问题大部分都没有涉及
对于糖尿病外周血管病变的治疗,2019年版IWGDF指南讲的比较少,无论是内科治疗还是介入治疗,这版的指南都讲得比较少(其实之前版本的IWGDF指南有关血管病变方面的内容更少),而国内糖尿病足指南,提到有关糖尿病外周血管病变治疗,一般都会用比较大的篇幅谈到其内科治疗。
人们对于糖尿病外周血管病变越来越关注,一方面,它是糖尿病足形成的最重要的原因;另一方面,它也是糖尿病进展到一定程度的标志,严重的糖尿病外周血管病变,往往标志着糖尿病进展到晚期,心、肾、脑、眼底等重要脏器的血管也存在严重的问题,而糖尿病足长期的皮肤溃疡不愈合,其产生的大量炎症因子,也会加重这些血管病变,因此,如何评价(诊断)及治疗糖尿病外周血管病变,成为了糖尿病诊断和治疗的最重要的领域。
糖尿病足的预防是各种指南中最重要的部分,无论是国内还是国外的,在各版的IWGDF指南都是重要内容,而且说明得特别详细及有比较多得循证医学的证据支持。但比较几个版本的IWGDF指南及国内外其他指南,这部分是肯定存在的,从中可以看出“糖尿病足的预防”已经深入人心。
伤口世界平台生态圈,以“关爱人间所有伤口患者”为愿景,连接、整合和拓展线上和线下的管理慢性伤口的资源,倡导远程、就近和居家管理慢性伤口,解决伤口专家的碎片化时间的价值创造、诊疗经验的裂变复制、和患者的就近、居家和低成本管理慢性伤口的问题。
2019广东省医疗行业协会伤口管理分会年会
扫一扫了解详情:
任何关于疾病的建议都不能替代执业医师的面对面诊断。所有门诊时间仅供参考,最终以医院当日公布为准。
网友、医生言论仅代表其个人观点,不代表本站同意其说法,请谨慎参阅,本站不承担由此引起的法律责任。